Skip to main content
Publication date
2018 10
Authors
Duruisseaux, M Martinez-Cardus, A Calleja-Cervantes, ME Moran, S de Moura, MC Davalos, V Pineyro, D Sanchez-Cespedes, M Girard, N Brevet, M Giroux-Leprieur, E Dumenil, C Pradotto, M Bironzo, P Capelletto, E Novello, S Cortot, A Copin, MC Karachaliou, N Gonzalez-Cao, M Peralta, S Montuenga, LM Gil-Bazo, I Baraibar, I Lozano, MD Varela, M Ruffinelli, JC Palmero, R Nadal, E Moran, T Perez, L Ramos, I Xiao, QY Fernandez, AF Fraga, MF Gut, M Gut, I Teixido, C Vilarino, N Prat, A Reguart, N Benito, A Garrido, P Barragan, I Emile, JF Rosell, R Brambilla, E Esteller, M
Author KI Usernames
Barragan, I|isabar
Pubmed ID
30100403
Journal
The Lancet. Respiratory medicine
Doctype
Article
KI Connection
Låg
Mesh SV
Behandlingsresultat DNA-metylering Epigenomik Forkhead-transkriptionsfaktorer Icke-småcelligt lungkarcinom Immunologiska cellgifter Kaplan-Meiers skattning Kvinnlig Lungtumörer Manlig Medelålders personer Monoklonala antikroppar, humaniserade Multivariantanalys Människa PD1-receptor Prediktivt värde av tester Proportional hazard-modeller Repressorproteiner Retrospektiva studier Tumörmarkörer Vuxna Äldre Äldre, 80 och över
Mesh EN
Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung DNA Methylation Epigenomics Forkhead Transcription Factors Kaplan-Meier Estimate Lung Neoplasms Multivariate Analysis Nivolumab Predictive Value of Tests Programmed Cell Death 1 Receptor Progression-Free Survival Proportional Hazards Models Repressor Proteins Retrospective Studies Treatment Outcome
First date
2018-10-21T23:41:19.571Z